Bionavigen

Bionavigen offers real world drug development experience-based consulting services for biologics including:

• Antibodies
• Peptides
• Recombinant proteins
• Bispecifics
• Antibody drug conjugates (ADC)
• Oncolytic virus (gene editing and gene delivery)
• Viral
• Cell
• Gene therapy
• Small molecule pharmaceuticals
• Therapeutic peptides
• Medical devices

Bionavigen Advantage:

• A team of virtual full drug developers (preclinical, clinical and regulatory experts)
• Actively engaged in acquisition of clinical stage biologics and small molecule drugs from pharmaceutical companies supported by funds from VC investment firms
• Support from early VC funding to early proof-of-concept clinical trials

Bionavigen Drug Hunting Services:

• Navigation of the current and future pipeline of the top ten biopharmaceutical companies
• Smart due diligence of potential out-licensing candidates using the latest scientific knowledge and soft intelligence
• Special emphasis on promising drug candidates in new disease indications or through new innovative combinations
• Investor backed drug acquisition and development through proof-of-concept